Skip to main content
OpenTrials
Completed

NCT Number: NCT02676934

End Tidal Control of Sevoflurane

the study compares the use of end tidal (Et) control of sevoflurane during anesthesia for living donor hepatectomy versus fresh gas (FGF) control. Et control is hypothesized to be as effective as FGF control with less cost and more operator satisfaction.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mansoura university

Al Mansurah, Dakahlia Governorate, 62215, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all donors scheduled for living donor hepatectomy in Mansoura liver transplant program

Exclusion criteria

  • refusal

Treatment and study plan

End tidal control module in Aisys anesthesia workstation

Device

THE USE OF AUTOMATED CONTROL OF END TIDAL SEVOFLURANE CONCENTRATION TO MAINTAIN ANESTHESIA DURING DONOR HEPATECTOMY

Primary outcomes

  1. cost of sevoflurane during anesthesia

    Time frame: Intra-operative period

Sponsors and collaborators

Lead sponsor

Mansoura University

Other

Registry information

Acronym: EtCntrl

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Feb 9, 2016
Registry last updated
Feb 9, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.